W.P. Steward - Concepedia

Author

W.P. Steward

The Christie Hospital

Also Known As

W P Steward, W Steward, W. P. Steward, W. Steward, W.P. Steward, WP Steward, William P Steward

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

The Christie Hospital

About

W.P. Steward is an author at The Christie Hospital specializing in oncology, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	259
2	Pathology	3	3	184
3	Public Health	1	1	52
4	Epidemiology	1	1	52
5	Global Health	1	1	52

W.P. Steward

Publications

973

Citations

H-Index

Page 1

	Year	Citations
Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Armando Santoro, T Türsz, Henning T. Mouridsen, Journal of Clinical Oncology	1995	526
Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer. N C Levitt, Ferry A.L.M. Eskens, Kenneth J. O’Byrne, PubMed Tumor ResponseChemoprevention StrategyPharmacological StudyMedicinePharmacology	2001	136
Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant marrow M Freshney, Lindsay McNair, Anne Parker, Blood	1996	85
Phase I/II study of gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results. W.P. Steward, Dunlop Dj, G Dabouis, PubMed	1996	58
Latest trends in cancer incidence among UK South Asians in Leicester Lucy Smith, J. L. Botha, A. Benghiat, British Journal of Cancer Epidemiology Of CancerCancer IncidenceCancer RegistrationYounger South AsiansSocial Determinants Of Health	2003	52
A multivariate analysis of factors affecting survival in patients with high-grade histology non-Hodgkin's lymphoma W.P. Steward, I D H Todd, Margaret Harris, European Journal of Cancer and Clinical Oncology Lymphoid NeoplasiaMedicinePrognosisPathologyRadiation Oncology	1984	31
Ifosfamide plus doxorubicin in previously untreated patients with advanced soft-tissue sarcoma. J. Schütte, Henning T. Mouridsen, W.P. Steward, PubMed	1993	24
Tallimustine is inactive in patients with previously treated small cell lung cancer. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group Jean Viallet, David J. Stewart, F. Shepherd, Lung Cancer National Cancer InstituteOncologyPhase Ii TrialCancer ManagementPharmacology	1996	23
Treatment of relapsed non-Hodgkin's lymphoma with a combination of hydroxyurea, ifosfamide, and etoposide. Gasser Ab, W.P. Steward, John Wagstaff, PubMed Lymphoid NeoplasiaMedicinePathologyLymphatic DiseaseOncology	1985	17
Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma Group. G. Blackledge, W.P. Steward, Jaap Verweij, PubMed	1992	11

Page 1